Home › Trial NCT03538717
"Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"
- Trial IDNCT03538717
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorPfizer
- Enrollment157
- Start date2018-04-19
- ConditionsCarcinoma, Renal Cell
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.